{"name":"DUSA Pharmaceuticals, Inc.","slug":"dusa-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":5275001,"netIncome":7319602,"cash":38022278,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Broad Area ALA 1-hour incubation","genericName":"Broad Area ALA 1-hour incubation","slug":"broad-area-ala-1-hour-incubation","indication":"Actinic keratosis","status":"phase_2"},{"name":"Broad Area ALA 2 hour incubation","genericName":"Broad Area ALA 2 hour incubation","slug":"broad-area-ala-2-hour-incubation","indication":"Actinic keratosis","status":"phase_2"}]}],"pipeline":[{"name":"Broad Area ALA 1-hour incubation","genericName":"Broad Area ALA 1-hour incubation","slug":"broad-area-ala-1-hour-incubation","phase":"phase_2","mechanism":"ALA (5-aminolevulinic acid) is a precursor to porphyrins, which accumulate in abnormal cells and become fluorescent under blue light, allowing for photodynamic therapy.","indications":["Actinic keratosis"],"catalyst":""},{"name":"Broad Area ALA 2 hour incubation","genericName":"Broad Area ALA 2 hour incubation","slug":"broad-area-ala-2-hour-incubation","phase":"phase_2","mechanism":"ALA (5-aminolevulinic acid) is a precursor to porphyrins, which accumulate in abnormal cells and become fluorescent under blue light, allowing for photodynamic therapy.","indications":["Actinic keratosis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNYnM0TmxtWEl6Zkl2U25iVlRMVXotTFNNY2lHSGIyV3QyX1pMc3A5a0tXOXkxSXZhdUJBc2JHS0hlUzF1WHczUGs1SlQ0U3JLRXRuSy1NdlQ3ak5PWW5Lb2NZQktTa3h3aGt2MURQVE0zQmY1UHB4V1E5OTQ0dTRQVkcwSHNRek5HQnBwdmxaaEMzSU1nRVVHUGNPdlZjSW8?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Leading Companies Fueling Growth and Innovation in the Actinic Keratosis Treatment Market - openPR.com","headline":"Leading Companies Fueling Growth and Innovation in the Actinic Keratosis Treatment Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPRC1udzVxUnZ0aFA4cVNrNzZOQnBwamhCZ2RjV1JPS05RNzRyVEF4akYyUlBKSnpwY3RBazhUZV9CWTAtSHQxVDlla3FoVDRYbmsxZlBtWGpKUmUtOThZRmdYNUxlUGNsZmpZQVNBZVUtZzFxYWM4OUFEc2k3NXhRcFB3?oc=5","date":"2023-10-13","type":"pipeline","source":"Dignity Memorial","summary":"Anna Houlihan Obituary - Congers, NY - Dignity Memorial","headline":"Anna Houlihan Obituary - Congers, NY","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-12-01","type":"pipeline","source":"Medical Dialogues","summary":"Sun Pharma arm DUSA Pharma to get Rs 170 crore in settlement with Biofrontera - Medical Dialogues","headline":"Sun Pharma arm DUSA Pharma to get Rs 170 crore in settlement with Biofrontera","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPT1dRMmxXZEhhMFViSmwwYmNIaUI3QVVpMUJCNXVWOUNOUk9IUGo0LS1EQVVFMTRnb3pXTlo3ZGpHQXIxaDY3VWYxYnZlN1FpREhIZk45bUU3VExXVm4wVmR5TTVna0NNYWF1dmRpM2Exd1FKeV9QMWdERGFkY25EejJiZnJ1ZmpDUDVfQktpSGVBUnVoT0JZNzM1N29nMnFoekpZblhVdy1pN0htM1BoYWlRTmlQRTRiMFFaS214WUtkZFFsaVQydjQwM0F2OGtKLWJMdGxGMDh2REpzZzJEN0lkYWhnWmhBQnc?oc=5","date":"2021-10-28","type":"patent","source":"IPWatchdog.com","summary":"Patent Filings Roundup: Intellectual Ventures Jumps Stalled Car Campaign; DJ against Mystery Sons of Innovation LLC; Another Hundred Suits Dismissed - IPWatchdog.com","headline":"Patent Filings Roundup: Intellectual Ventures Jumps Stalled Car Campaign; DJ against Mystery Sons of Innovation LLC; Ano","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQOHpRVkJfZDE1a1B3TlQ0cmFNYlFIbmZ4MmR4UHVTZ1l0VmNqQ0tsRzVIOWItSktvMS1RWVFWS0RUeko1YjFPcjJJZUNLYTVMNVlPdzZ2M0Y4SjVIYXBHWV93dHAwVGFvazFWemZHM0pENjNmazNUN21fTUxkRjY5VnFMNnRpemhyUWFGbUkwUE5pYkNSek8yRkcyVG8xaENwSjNSZFlCeEZzR3dEaXRtbzNhRTFLZ3VWc1RzY1NuRkJFdmxtMXE0TTNn?oc=5","date":"2020-08-24","type":"pipeline","source":"PR Newswire","summary":"DUSA Resolves Investigation Related to Promotion of Actinic Keratosis Drug - PR Newswire","headline":"DUSA Resolves Investigation Related to Promotion of Actinic Keratosis Drug","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-12-27","type":"patent","source":"ET HealthWorld","summary":"Sun Pharma arm gets relief from US court in patent infringement case - ET HealthWorld","headline":"Sun Pharma arm gets relief from US court in patent infringement case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1iMnBQQVoxRWk4S2hrSmZGZTM4em5EWDFCcVpadkJLVTVHVTBNa2xTbENxVklid1BaMENHUXpuMFdhVjlXc0hCVm8zTlRJR28tTEYxenhUaXhoOFlVVEpmYzl5b0ZGY3hWT1Z4ZDhOSnItQQ?oc=5","date":"2017-01-17","type":"pipeline","source":"YourStory.com","summary":"From son of a pharmaceutical trader to India’s second richest man – Dilip Shanghvi’s incredible story - YourStory.com","headline":"From son of a pharmaceutical trader to India’s second richest man – Dilip Shanghvi’s incredible story","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9GaW53My1IUmQzd1BJVmVqQXVTRGswem1kWVU3WkFrVTdnZVVRbElac29WYWVaVDVneVl4d0dNYkF2U3VLWWI2Skt0NWJsV2VySmF2ZVRTVE85bUpsRmhGUG5Fc1FGS3kwcGlv?oc=5","date":"2015-06-09","type":"pipeline","source":"Luxatic","summary":"Dilip Shanghvi and Sun Pharmaceuticals - Luxatic","headline":"Dilip Shanghvi and Sun Pharmaceuticals","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2015-03-26","type":"deal","source":"Mint","summary":"Sun Pharma completes Ranbaxy deal - Mint","headline":"Sun Pharma completes Ranbaxy deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxNZ09jdGg1UUcyWnFteHl1ZEZOck1aRnRLckNocTMycXhJcXdSTWJ1bGpPVkF5ZFZTM2Vqcmc2V24zSWFjY1pBd213d19ScVBzTzhLQXk0V0xySmc5OU51cEV1RHBBZVA5eDhhUk5GdVNMUDZMNjZQR29MT3llOTBtd2lyOS1yTzdoZ1lWYkw4bHRBbHR0dDJrNlpnWU5VcHBjem42Z1JoWlF4VmlTc2dhN3RnaVNQRGpxa3JUZHRUV1VvUmk4OWlCU1pfNEVrVEptRy1kLVJZb0p2WU1kTmlNQlBrR0pwU3VD?oc=5","date":"2012-11-08","type":"deal","source":"The Economic Times","summary":"Sun Pharma to acquire US dermatology company DUSA Pharma - The Economic Times","headline":"Sun Pharma to acquire US dermatology company DUSA Pharma","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":null,"revenuePeriod":null,"revenueHistory":[],"grossProfit":null,"grossProfitHistory":[],"rdSpend":5275001,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":7319602,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":38022278,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}